Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.

At higher concentrations, KPL-404 appeared to more effectively inhibit IC-induced B cell CD69 expression, although the difference did not reach statistical significance.

also in 111,027 other papers